SVA

Sinovac Biotech, Ltd
SVA

Overview Fund Activity
Delisted

SVA was delisted on the 22nd of February, 2019.

Back to rankings

28 hedge funds and large institutions have $93.4M invested in Sinovac Biotech, Ltd in 2018 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
-1
Holders Change %
-3.45%
% of All Funds
0.64%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
5
Increased
6
Reduced
7
Closed
6
Calls
$289K
Puts
$300K
Net Calls
-$11K
Net Calls Change
-$109K

Top Buyers

1
VC
1
Vivo Capital
California
$45M
2
Invesco
2
Invesco
Georgia
$619K
3
SCP
3
Seizert Capital Partners
Michigan
$275K
4
Northern Trust
4
Northern Trust
Illinois
$170K
5
YMRC
5
Yorktown Management & Research Company
Virginia
$537K

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$18.7M
2
Deutsche Bank
2
Deutsche Bank
Germany
$0
3
NAH
3
Neumann Advisory (HK)
Hong Kong
$2.85M
4
SG Americas Securities
4
SG Americas Securities
New York
$0
5
State Street
5
State Street
Massachusetts
$943K
Name Holding Trade Value Shares
Change 		Shares
Change %
TRCT
26
Tower Research Capital (TRC)
New York
$2K +$2K +260 New
GWM
27
Geneos Wealth Management
Colorado
$1K – – –
Bank of America
28
Bank of America
North Carolina
$1K +$1K +94 New
Deutsche Bank
29
Deutsche Bank
Germany
– -$547K -73,337 Closed
SG Americas Securities
30
SG Americas Securities
New York
– -$179K -24,021 Closed
Barclays
31
Barclays
United Kingdom
– -$83K -11,100 Closed
Millennium Management
32
Millennium Management
New York
– -$76K -10,195 Closed
1
2